Nine Approval for Medical Devices PLI
[Min of Chemicals and Fertilizers/11.02.2021]
The Medical Device Sector in India suffers from a
considerable cost of manufacturing disability vis-à-vis competing economies, inter
alia, on account of lack of adequate infrastructure,
domestic supply chain and logistics, high cost of finance, inadequate availability
of power, limited design capabilities, low focus on research and development (R&D)
and skill development etc.
With an objective to boost domestic
manufacturing, attract large investment in Medical Device Sector, the Department
of Pharmaceuticals had launched a Production Linked Incentive
(PLI) Scheme for Promotion of Domestic Manufacturing of Medical Devices to ensure a level playing field for the domestic manufacturers of medical
devices with a total financial outlay of Rs.3,420 cr. for the period 2020-21
to 2027-28.
The applications under four different Target Segments
including “Cancer care/Radiotherapy Medical Devices”, “Radiology & Imaging Medical
Devices (both ionizing & non-ionizing radiation products) and Nuclear Imaging
Devices”, "Anaesthetics & Cardio-Respiratory
Medical Devices including Catheters of Cardio-Respiratory Category & Renal Care
Medical Devices” and “All Implants including Implantable Electronic Devices” were
invited.
The Government has approved applications of following
applicants, which fulfill the prescribed laid down criteria, as under:
|
Sl.No. |
Name of approved Applicant |
Name of Eligible Product |
Committed Investment (in Rs. crores) |
|
1. |
M/s Siemens Healthcare Private Limited |
CT Scan and MRI |
91.91 |
|
2. |
M/s Allengers
Medical Systems Limited (AMSL) |
CT Scan, MRI, Ultrasonography, X-Ray, Cath
Lab, Positron Emission Tomography (PET) Systems, Single Photon Emission Tomography (SPECT), Mammography and C arm. |
50.00 |
|
3. |
M/s Allengers
OEM Private Limited (AOPL) |
X Ray Tubes, Collimators, Flat Panel Detector
and Monitors’ |
40.00 |
|
4. |
M/s Wipro GE Healthcare Private Limited
(WGHPL) |
‘CT Scan’, ‘Cath Lab’ and ‘Ultrasonography’ |
50.22 |
|
5. |
M/s Nipro India
Corporation Private Limited (NICPL) |
‘Dialyzer’ |
180.00 |
|
6. |
M/s Wipro GE Healthcare Private Limited
(WGHPL) |
‘Anaesthesia Unit
Ventilator’ and ‘Patient Monitor’ |
53.86 |
|
7. |
M/s Sahajanand
Medical Technologies Private Limited (SMTPL) |
‘Heart Valves’, ‘Stents’, ‘PTCA Balloon Dilatation
Catheter’ and ‘Heart Occluders’ |
166.89 |
|
8. |
M/s Innvolution
Healthcare Private Limited (IHPL) |
‘Stents’ and ‘PTCA Balloon Dilation Catheter’ |
21.75 |
|
9. |
M/s Integris
Health Private Limited (IHPL) for Eligible Products |
Transcatheter Aortic Heart Valve |
75.00 |
The setting up of these plants will lead to a total
committed investment of Rs. 729.63 crore by the companies
and employment generation of about 2,304. The commercial production is projected
to commence from 1st April, 2022 and the disbursal of production linked
incentive by the Government over the five years period would be up to a maximum
of Rs.121.00 crore per applicant per target segment. The setting of these plants
will make the country self-reliant to a large extent in the specified target segments
in the Medical Devices Sector. The remaining pending applications are proposed to
be taken up for approval by end of February, 2021.